Humana stock slides as Cigna confirms it won’t pursue a combination

Humana stock slides as Cigna confirms it won’t pursue a combination
Humana drops amid Cigna comments on using cash for buybacks; may dampen takeover spec
Humana, Cigna talks informal at best, no developments expected soon - CTFN
Amid renewed chatter of Cigna acquiring Humana, Street has reservations
Potential Cigna buyout of Humana is a ‘when,’ not an ‘if,’ analyst says
Cigna seeks to disqualify FTC Chair Lina Khan from insulin case because of alleged bias
79.64BUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
NYSE
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US1255231003
CUSIP
125523100
Sector
Healthcare
Industry
Healthcare Plans
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
12.76
PEG Ratio
0.90
Book Value
159.52
Dividend Share
6.09
Dividend Yield
2.02%
Earnings Share
23.24
Wall Street Target Price
340.92
EPS Estimate Current Year
30.41
EPS Estimate Next Year
33.48
EPS Estimate Current Quarter
7.6063
EPS Estimate Next Quarter
7.4502
Most Recent Quarter
-
Revenue TTM
277,892,005,888
Gross Profit TTM
25,423,998,976
EBITDA
13,390,000,128
Profit Margin
2.26%
Return On Assets TTM
4.78%
Return On Equity TTM
16.27%
Revenue Per Share TTM
1049.783
Qtly Revenue Growth YOY
4.60%
Diluted Eps TTM
23.24
Qtly Earnings Growth YOY
29.10%
Trailing PE
12.76
Forward PE
9
Price Sales TTM
0.2822
Price Book MRQ
1.8868
Enterprise Value Revenue
0
Enterprise Value EBITDA
8
62.22
2.40%379.84
1.04%15.09
-19.02%4.20
-3.56%414.30
-1.71%31.09
-1.41%31.01
-1.12%363.00
-0.93%104.43
-0.70%193.66
-0.58%